SCHEMBL13304336

SCHEMBL13304336

Cc1cccc(N(c2cccc(C)c2)c2cc3ccc4cc(N(c5cccc(C)c5)c5cccc(C)c5)cc5ccc(c2)c3c45)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.42
▸ CYP1A2 P05177 4/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ CYP51A1 Q16850 1/20 0.39
▸ SIGMAR1 Q99720 2/20 0.37
▸ CYP2A6 P11509 4/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304307 0.94 TDP1 (0.39) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL17030411 0.88 CYP1A2 (0.45) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL5823395 0.88 ACHE (0.46) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL13304339 0.86 TSHR (0.34) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL13304337 0.86 TSHR (0.36) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL29391727 0.85 ACHE (0.52) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL147931 0.85 ACHE (0.52) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL977663 0.85 ACHE (0.58) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL883714 0.83 ACHE (0.57) ACHECYP1A2TDP1LMNAMAPK1
SCHEMBL8766625 0.83 ACHE (0.50) ACHECYP1A2TDP1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1437395-B2 Organic electroluminescent device LG DISPLAY CO LTD (KR) 2015-08-26 — — EP disclosed
US-8436344-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2013-05-07 — — US disclosed
EP-1437395-B1 Organic electroluminescent device LG DISPLAY CO LTD (KR) 2011-12-14 — — EP disclosed
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2010-06-24 — — US disclosed
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2010-06-24 — — US disclosed
US-7700201-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-04-20 — — US disclosed
US-7700201-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE L1CAM, AOC2, AOC1 ACHE 126/4885CYP1A2 223/4885TDP1 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback